Esseti Farmaceutici Srl, a prominent player in the pharmaceutical industry, is headquartered in Italy and operates extensively across various regions. Founded in 1990, the company has established itself as a leader in the development and production of high-quality pharmaceutical products, particularly in the fields of dermatology and gynaecology. With a commitment to innovation, Esseti Farmaceutici offers a unique range of prescription medications and over-the-counter solutions that cater to diverse healthcare needs. The company’s dedication to research and development has led to significant milestones, enhancing its market position and reputation for excellence. Recognised for its quality and efficacy, Esseti Farmaceutici continues to make strides in improving patient outcomes and advancing healthcare solutions globally.
How does Esseti Farmaceutici Srl's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Esseti Farmaceutici Srl's score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Esseti Farmaceutici Srl, headquartered in Italy, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Esseti Farmaceutici Srl may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Esseti Farmaceutici Srl to consider developing and communicating their climate strategies to align with industry standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Esseti Farmaceutici Srl has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

